Milrinone Lactate is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hikma Pharmaceuticals Usa Inc.. The primary component is Milrinone Lactate.
| Product ID | 0143-9710_99ef3368-bf2e-4c42-b183-ec5f6d7fd187 |
| NDC | 0143-9710 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Milrinone Lactate |
| Generic Name | Milrinone Lactate |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2010-12-03 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA077966 |
| Labeler Name | Hikma Pharmaceuticals USA Inc. |
| Substance Name | MILRINONE LACTATE |
| Active Ingredient Strength | 1 mg/mL |
| Pharm Classes | Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2010-12-03 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA077966 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-12-03 |
| Marketing Category | ANDA |
| Application Number | ANDA077966 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-12-03 |
| Marketing End Date | 2011-05-19 |
| Marketing Category | ANDA |
| Application Number | ANDA077966 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-12-03 |
| Marketing End Date | 2011-05-19 |
| Marketing Category | ANDA |
| Application Number | ANDA077966 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2011-05-19 |
| Marketing Category | ANDA |
| Application Number | ANDA077966 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2010-12-03 |
| Marketing End Date | 2011-05-19 |
| Ingredient | Strength |
|---|---|
| MILRINONE LACTATE | 1 mg/mL |
| SPL SET ID: | 88f78780-399f-4780-be19-205739db1682 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |